Idorsia will publish its Half Year 2024 Financial Reporting on Thursday July 25, 2024, at 07:00 CEST.
An investor conference call and webcast will be held to discuss the results on the same day.
Date:Thursday, July 25, 2024
Time:15:00 CEST / 14:00 BST / 09:00 EDT
The call will start with presentations by senior management, followed by a Q&A session.
To support your preparations, the consensus estimates can be found under: www.idorsia.com/consensus-estimate (http://www.idorsia.com/consensus-estimate).
Dial-inprocedure:
1) Participants are required to register in advance of the conference (link already open for registration) using the link provided below. Upon registration, each participant will be provided with participant dial in numbers, and a unique personal PIN.
2) In the 10 minutes prior to the call start time, participants will need to use the conference access information provided in the e-mail received at the point of registering. Participants may also use the Call Me feature instead of dialing the nearest dial in number.
Online Registration:https://register.vevent.com/register/BI69879d85d78c4b5c98cadf7dc341a313 (https://register.vevent.com/register/BI69879d85d78c4b5c98cadf7dc341a313)
Webcast: Participants should go to the Idorsia website www.idorsia.com (http://www.idorsia.com) 10-15 minutes before the conference is due to start.
Replay: A replay of the investor webcast will be available through www.idorsia.com (http://www.idorsia.com) approximately 60 minutes after the call has ended.
Kind regards,
Andrew C. Weiss
Head of Investor Relations and Corporate Communications
Attachment
- Press Release PDF (https://ml-eu.globenewswire.com/Resource/Download/0b1ae54e-e3c3-4568-8d02-f3a7f828e3cc)
![](https://ml-eu.globenewswire.com/media/NmYwZGYyNWUtOGQ5OS00MTRiLTgwYTgtYmM1M2IwNTYyNTcwLTEwOTc0MjE=/tiny/Idorsia-Pharmaceuticals-Ltd.png)